Dr Nandor Roczo is the Regional Manager for Australia and New Zealand for Invitae, one of the largest clinical diagnostic companies in the world. He undertook his PhD with the Department of Surgery (University of Melbourne, RMH and WHF) at the Peter MacCallum Cancer Centre in molecular biology (colorectal cancer research) in 2003. Dr Roczo completed his post-doctoral research studies at the Univeritè de Paris Sud XI in neurological research after which he embarked on a career in the private sector around human health. Dr Roczo is passionate about contributing to the betterment of healthcare through the removal of barriers to access to genetic testing and the reinforcement of support networks post testing.
Abstracts this author is presenting: